MedPath

Vytronus, Inc.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
3 (100.0%)

Clinical Investigation of the VytronUS Ablation System for Treatment of Paroxysmal Atrial Fibrillation

Not Applicable
Completed
Conditions
Paroxysmal Atrial Fibrillation
First Posted Date
2018-08-21
Last Posted Date
2019-04-24
Lead Sponsor
VytronUS, Inc.
Target Recruit Count
53
Registration Number
NCT03639597
Locations
πŸ‡¨πŸ‡Ώ

Na Homolce, Prague, Czechia

Clinical Investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation

Not Applicable
Conditions
Paroxysmal Atrial Fibrillation
First Posted Date
2018-05-01
Last Posted Date
2018-05-01
Lead Sponsor
VytronUS, Inc.
Target Recruit Count
100
Registration Number
NCT03513029
Locations
πŸ‡¨πŸ‡Ώ

Na Homolce, Prague, Czechia

A Study of the Safety and Efficacy of the VytronUS Low-Intensity Collimated Ultrasound Ablation System

Not Applicable
Completed
Conditions
Paroxysmal Atrial Fibrillation
First Posted Date
2013-07-16
Last Posted Date
2015-06-29
Lead Sponsor
VytronUS, Inc.
Target Recruit Count
7
Registration Number
NCT01900678
Locations
πŸ‡¨πŸ‡Ώ

Na Homolce Hospital, Prague, Czech Republic

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.